ELAN

22.55

0.62% 0.14

Dopo l'orario di chiusura: 22.55

Elanco Animal Health Inc (ELAN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$22.41

Aprire:

$22.38

Volume 24 ore:

4.94M

Relative Volume:

1.05

Capitalizzazione di mercato:

$11.27B

Reddito:

$4.89B

Utile/perdita netta:

$-242.00M

Rapporto P/E:

-46.11

EPS:

-0.489

Flusso di cassa netto:

$315.00M

1 W Prestazione:

+0.85%

1M Prestazione:

-2.59%

6M Prestazione:

-6.47%

1 anno Prestazione:

+11.52%

Intervallo 1D:

$22.26

$22.92

Intervallo di 1 settimana:

$22.00

$22.98

Portata 52W:

$19.40

$27.98

Elanco Animal Health Inc Stock (ELAN) Company Profile

Nome

Elanco Animal Health Inc

Settore

Healthcare (1051)

Industria

Drug Manufacturers - Specialty & Generic (84)

Telefono

877-352-6261

Indirizzo

450 ELANCO CIRCLE, INDIANAPOLIS

Dipendente

9,900

Cinguettio

@Elanco

Prossima data di guadagno

2026-11-06

Ultimi documenti SEC

ELAN's Discussions on Twitter

Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ELAN Elanco Animal Health Inc	22.55	11.27B	4.89B	-242.00M	315.00M	-0.489
TAK Takeda Pharmaceutical Co Adr	19.01	60.73B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	40.72	47.49B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.68	42.57B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	75.29	31.11B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	540.03	23.16B	3.17B	1.29B	1.01B	27.09

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-15	Iniziato	Citigroup	Buy
2026-01-22	Aggiornamento	Piper Sandler	Neutral → Overweight
2025-12-09	Iniziato	Barclays	Overweight
2025-11-21	Iniziato	KeyBanc Capital Markets	Overweight
2025-11-19	Aggiornamento	Argus	Hold → Buy
2025-10-07	Aggiornamento	JP Morgan	Neutral → Overweight
2025-07-17	Aggiornamento	Leerink Partners	Market Perform → Outperform
2025-06-26	Aggiornamento	William Blair	Mkt Perform → Outperform
2024-12-09	Iniziato	UBS	Buy
2024-12-02	Iniziato	Leerink Partners	Market Perform
2024-09-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-01-05	Aggiornamento	Stifel	Hold → Buy
2023-12-19	Iniziato	Jefferies	Buy
2023-12-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Iniziato	Exane BNP Paribas	Outperform
2023-04-20	Aggiornamento	Barclays	Equal Weight → Overweight
2022-08-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Downgrade	JP Morgan	Overweight → Neutral
2022-07-21	Downgrade	Goldman	Buy → Sell
2022-07-12	Iniziato	Piper Sandler	Neutral
2021-11-18	Iniziato	Morgan Stanley	Overweight
2021-10-28	Downgrade	Stifel	Buy → Hold
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-06-15	Aggiornamento	Cleveland Research	Underperform → Neutral
2021-05-11	Aggiornamento	Barclays	Underweight → Equal Weight
2021-05-11	Aggiornamento	Gabelli & Co	Hold → Buy
2021-04-15	Iniziato	Stifel	Buy
2021-03-22	Downgrade	Gabelli & Co	Buy → Hold
2021-02-26	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-12-09	Downgrade	Argus	Buy → Hold
2020-11-09	Downgrade	Barclays	Overweight → Underweight
2020-08-20	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Ripresa	Credit Suisse	Neutral
2020-08-04	Ripresa	Goldman	Buy
2020-07-27	Downgrade	Cleveland Research	Neutral → Underperform
2020-04-02	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Iniziato	Raymond James	Mkt Perform
2019-12-19	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-11-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Iniziato	Barclays	Overweight
2019-08-26	Downgrade	BofA/Merrill	Buy → Neutral
2019-08-15	Aggiornamento	UBS	Sell → Neutral
2019-05-23	Iniziato	Guggenheim	Neutral
2019-03-18	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-03-13	Ripresa	Morgan Stanley	Equal-Weight
2019-02-12	Iniziato	William Blair	Mkt Perform
2019-01-23	Iniziato	UBS	Sell
2019-01-15	Iniziato	Argus	Buy
2018-10-15	Iniziato	Morgan Stanley	Equal-Weight

Mostra tutto

Elanco Animal Health Inc Borsa (ELAN) Ultime notizie

Oct 01, 2026

Deferring cash fees, Elanco (ELAN) director Kapila K. Anand acquires 642 stock-linked units. - stocktitan.net

Oct 01, 2026

Sep 22, 2026

Elanco Animal Health CEO Jeffrey N. Simmons Reports Acquisition of Deferred Stock Units - Kalkine Media

Sep 22, 2026

Form 4 Elanco Animal Health For: 22 September By Investing.com - Investing.com Nigeria

Sep 22, 2026

Form 4 Elanco Animal Health For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026

Elanco Animal Health Incorporated (ELAN) Latest Press Releases & Corporate News - finance.yahoo.com

Sep 11, 2026

Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement - Yahoo Finance

Sep 11, 2026

Sep 10, 2026

Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - PR Newswire

Sep 10, 2026

Sep 09, 2026

Elanco Animal Health (ELAN) CFO receives 8 deferred stock units - Stock Titan

Sep 09, 2026

Deferred stock award lifts Elanco Animal Health (NYSE: ELAN) exec's holdings - Stock Titan

Sep 09, 2026

Elanco (NYSE: ELAN) CEO adds to deferred pay with new stock grant - Stock Titan

Sep 09, 2026

Elanco Animal Health (ELAN) 10K Form and Latest SEC Filings 2026 - MarketBeat

Sep 09, 2026

Sep 08, 2026

Mutts With a Mission: How Elanco and Medical Mutts Transform Lives Together - CSRwire

Sep 08, 2026

Sep 04, 2026

Elanco Animal Health Stock Price Forecast. Should You Buy ELAN? - StockInvest.us

Sep 04, 2026

Elanco Director Purchases 40,000 Shares for $936,000 - Yahoo Finance

Sep 04, 2026

Elanco Director Purchases 40,000 Shares for $936,000 - The Motley Fool

Sep 04, 2026